Skip to content

Drug interactions

Elagolix + Nimodipine

Severity: Moderate

Elagolix and Nimodipine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Elagolix is a weak-to-moderate CYP3A inducer and may lower nimodipine exposure. Reduced plasma concentrations could weaken the cerebrovascular protective effect of nimodipine, for example after subarachnoid hemorrhage.

What this interaction means in plain words

Elagolix and Nimodipine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Elagolix belongs to Musculoskeletal; Nimodipine belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Induction of CYP3A4 by elagolix increases the first-pass and hepatic metabolism of nimodipine.

What to do

Monitor clinical response and blood pressure when elagolix is started or stopped. Consider a nimodipine dose adjustment if efficacy appears reduced.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Elagolix and Nimodipine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Elagolix with Nimodipine?

MediHelp rates the interaction as moderate. Elagolix and Nimodipine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Elagolix is a weak-to-moderate CYP3A inducer and may lower nimodipine exposure. Reduced plasma concentrations could weaken the cerebrovascular protective effect of nimodipine, for example after subarachnoid hemorrhage.

How serious is the interaction between Elagolix and Nimodipine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor clinical response and blood pressure when elagolix is started or stopped. Consider a nimodipine dose adjustment if efficacy appears reduced.

What other medicines interact with Nimodipine?

MediHelp also lists interactions of Nimodipine with, for example, Apalutamide, Carbamazepine, Ceritinib. The full list is on the Nimodipine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in